| Similarity | Rank | |
|---|---|---|
| Trials | 0.761 | 22492 |
| trial | 0.757 | 1946 |
| placebo-controlled | 0.714 | 42426 |
| double-blind | 0.711 | 34234 |
| randomised | 0.707 | 46929 |
| randomized | 0.704 | 18214 |
| multicenter | 0.701 | 69465 |
| RCTs | 0.683 | 82390 |
| clinical | 0.682 | 2463 |
| preclinical | 0.682 | 49806 |
| investigational | 0.680 | 62099 |
| open-label | 0.671 | 89583 |
| efficacy | 0.664 | 9929 |
| pre-clinical | 0.664 | 79324 |
| tribulations | 0.652 | 31535 |
| studies | 0.647 | 1235 |
| meta-analysis | 0.637 | 39189 |
| regimens | 0.630 | 28116 |
| Randomized | 0.630 | 93743 |
| Herceptin | 0.625 | 84291 |
| well-controlled | 0.624 | 96583 |
| thalidomide | 0.619 | 97242 |
| tolerability | 0.619 | 68898 |
| epidemiological | 0.613 | 36173 |
| investigations | 0.613 | 8006 |